footnote_entry

TL3 Regular · Augsburg, DE

Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.

Joined 10 January 2025 · last posted 3d · groups: pharmacists

129 posts, newest first. Showing up to 150.

Here for the analytics and not much else Replied, post #91 · Lounge › Introductions · 25 Jul 2026 · 14 likes Clinician voices are genuinely welcome and are asked to be explicit about the line. Several members here say plainly in every post that they are describing general…
What a certificate commits its issuer to Replied, post #101 · Analytics › COA interpretation · 25 Jul 2026 · 22 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
Follow-up: Signs of dehydration worth acting on Replied, post #37 · Safety › Adverse events · 24 Jul 2026 · 0 likes Answering the question post #36 raises rather than the one it answers. Acute kidney injury: rare but reported. Symptoms (decreased urine output, creatinine elevation)…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #145 · Sourcing › Logistics · 24 Jul 2026 · 7 likes The arithmetic on Regional warehouse stock versus direct is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and…
Research-use-only status: what it means legally and practically Replied, post #80 · Compounds › Other compounds · 23 Jul 2026 · 5 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Prior authorisation: what the criteria usually require — a second dataset Replied, post #55 · Access › Insurance & coverage · 22 Jul 2026 · 17 likes The confident answers on Prior authorisation and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #127 · Evidence › Journal club · 21 Jul 2026 · 0 likes This is the sort of exchange that makes the archive worth searching.
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #40 · Practice › Interactions · 18 Jul 2026 · 11 likes Answering the question post #38 raises rather than the one it answers. One more thing on Delayed gastric emptying and oral that took me far too long to see: the two…
A site rotation scheme that is easy enough to actually follow — a second dataset Replied, post #8 · Practice › Administration · 18 Jul 2026 · 1 like Adding the measurement that post #5 says would settle it. Pinching a fold is useful for lean tissue and unnecessary elsewhere. The point is to keep the needle out of…
Second pass at: Absence of evidence and evidence of absence Replied, post #48 · Research Methods › Statistics · 18 Jul 2026 · 0 likes Having read the whole Absence of evidence thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #42 · Analytics › HPLC & UHPLC · 16 Jul 2026 · 0 likes Reporting rather than recommending, on Detection wavelength. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
Insurance and replacement policies, compared Replied, post #93 · Sourcing › Logistics · 16 Jul 2026 · 0 likes Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what you are protecting against.
What I would want from a home test that does not exist yet — what changed since Replied, post #95 · Analytics › Home & field testing · 15 Jul 2026 · 30 likes Weighing vials against declared fill is the most underrated home check available. It needs a balance with adequate resolution and it catches fill problems that no…
Primary endpoint hierarchies and why order matters — one year on Replied, post #44 · Evidence › Trials · 12 Jul 2026 · 1 like Clear enough that I do not think I have a follow-up, which is unusual.
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #29 · Compounds › Retatrutide · 10 Jul 2026 · 0 likes I keep a log for glucagon receptor agonist specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing…
Prescription portability between countries Replied, post #89 · Access › International · 6 Jul 2026 · 7 likes Post #85 describes the usual case. This is about the unusual one. Source for the prescription portability between countries figure, since it was asked for. It is in the…
The anatomy of a question that gets answered within an hour Replied, post #93 · Start Here › How to Ask · 28 Jun 2026 · 4 likes Fair, and the limits you put on it are the part I will remember.
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #85 · Data & Tools › Datasets · 24 Jun 2026 · 3 likes Adding the measurement that post #84 says would settle it. Self-reported, unblinded, self-selected data has known biases and is still worth collecting, provided every…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #84 · Evidence › Preprints · 20 Jun 2026 · 2 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
Fasting versus non-fasting and which tests care Replied, post #50 · Clinical › Bloodwork · 17 Jun 2026 · 0 likes Reframing fasting versus non-fasting slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes.…
What I would want from a home test that does not exist yet Replied, post #12 · Analytics › Home & field testing · 16 Jun 2026 · 13 likes Where I part company with post #10, and it is a narrow parting. What you can use home tests for: confirmation that a solution contains peptide (as opposed to being…
Pooling trials with different estimands Replied, post #25 · Evidence › Meta-analyses · 14 Jun 2026 · 5 likes This follows post #23 rather than contradicting it. Fixed-effect and random-effects models answer different questions. The first assumes one true effect; the second…
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #27 · Practice › Reconstitution · 14 Jun 2026 · 13 likes Post #24 answers the question as asked. The question underneath it is different. Preservative effectiveness is tested against a defined microbial challenge under…
Designing a personal experiment that could change your mind — one year on Replied, post #59 · Research Methods › N-of-1 designs · 12 Jun 2026 · 1 like Useful. I had the fact and not the reason, which turns out to be the important half.
Does dual agonism explain the effect size, or is it dose? Replied, post #24 · Compounds › Tirzepatide · 8 Jun 2026 · 22 likes The arithmetic in post #21 is right; the assumption feeding it is the part to check. The dual agonism is not a marketing framing — GIP receptor and GLP-1 receptor…
Request: a per-category review queue Replied, post #8 · Meta › Feature requests · 28 May 2026 · 2 likes Adding a data point of agreement rather than a data point.
Injection volume, overload, and peak distortion Replied, post #21 · Analytics › HPLC & UHPLC · 26 May 2026 · 3 likes Understood, and I withdraw the assumption I opened with.
The "under review" status pill and when a moderator applies it Replied, post #115 · Evidence › Preprints · 5 May 2026 · 4 likes Taking post #112 at face value and following it one step further. Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends…
A single out-of-range value on an otherwise normal panel Replied, post #42 · Clinical › Bloodwork · 4 May 2026 · 9 likes General information rather than advice about anyone's care. A single value outside a reference interval, on a single draw, in an otherwise unremarkable panel, is…
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #49 · Start Here › Welcome · 30 Apr 2026 · 0 likes If you are not sure which subcategory a question belongs in, post it in the closest one. A moderator will move it, the move is logged, and nothing bad happens to you. I…
List price versus negotiated price versus what you pay Replied, post #108 · Access › Pricing · 17 Apr 2026 · 0 likes List price versus negotiated price is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until…
[2026 update] Composite endpoints and the component doing the work Replied, post #73 · Evidence › Trials · 17 Apr 2026 · 0 likes I read post #69 twice before replying, because I had assumed the opposite. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a…
Sample handling between despatch and injection Replied, post #43 · Analytics › Method validation · 16 Apr 2026 · 31 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
Journal club: LEADER as the historical anchor Replied, post #60 · Evidence › Journal club · 14 Apr 2026 · 1 like Post #57 describes the usual case. This is about the unusual one. The most useful reply I ever got about LEADER was a request to state my units. It sounds like pedantry…
Revisiting: Drawing up with one needle and injecting with another Replied, post #21 · Practice › Administration · 2 Apr 2026 · 5 likes Coming back to post #17, because the follow-up matters more than the original answer. If you have to inject at a different time of day than usual, that is a much…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #76 · Practice › Interactions · 28 Mar 2026 · 0 likes Narrowing post #75, because the general version has more than one answer. Two sentences on Common supplements and then I will stop, because the rest is speculation and…
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #15 · Evidence › Journal club · 26 Mar 2026 · 14 likes Confirming post #13 from a second method, which matters more than confirming it from a second person. For anyone finding this later: the short answer on SURMOUNT-4 and…
[2026 update] What a purity-only report leaves out Replied, post #63 · Sourcing › Independent verification · 23 Mar 2026 · 23 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which.
Foaming during reconstitution and whether it matters — the long version Replied, post #69 · Practice › Reconstitution · 20 Mar 2026 · 4 likes Quietly grateful for the plain phrasing. Not every thread gets that.
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #77 · Practice › Storage & stability · 7 Mar 2026 · 20 likes The strongest argument against my own position on Storing lyophilised material long term, stated as well as I can state it, since nobody else has yet.
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #45 · Sourcing › Logistics · 25 Feb 2026 · 0 likes The arithmetic in post #43 is right; the assumption feeding it is the part to check. Import restrictions by jurisdiction: what is legal to import for personal use…
How to ask about something you suspect is a bad idea Replied, post #55 · Start Here › How to Ask · 15 Feb 2026 · 0 likes This follows post #52 rather than contradicting it. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you…
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #38 · Outcomes › Progress reports · 11 Feb 2026 · 20 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #32 · Practice › Interactions · 8 Jan 2026 · 1 like Post #31 answers the question as asked. The question underneath it is different. Anything that also slows gut motility compounds the same mechanism. That is a…
Preprint servers and what screening they do Replied, post #15 · Evidence › Preprints · 4 Jan 2026 · 9 likes Reading a preprint properly means doing some of the reviewer's job: methods first, then whether the analysis matches the plan, then the conclusion. That holds under the…
Vomiting: when it is expected and when it is a reason to stop Replied, post #65 · Practice › Side effects · 28 Dec 2025 · 1 like The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
Why "add 2 mL" is not an instruction Replied, post #20 · Practice › Reconstitution · 22 Dec 2025 · 6 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
The headache that turns out to be dehydration Replied, post #97 · Nutrition & Training › Hydration & electrolytes · 16 Dec 2025 · 0 likes Orthostatic symptoms: dizziness on standing after lying down can indicate dehydration or electrolyte depletion. Increasing fluids, salt, and potassium usually resolves…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #11 · Sourcing › Red flags · 10 Dec 2025 · 22 likes Post #8 is right about the mechanism and I think understates the practical bit. Unresponsiveness: a supplier that does not reply to reasonable requests for…
Robustness: the parameters worth deliberately varying Replied, post #53 · Analytics › Method validation · 9 Dec 2025 · 0 likes On robustness, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting…
Why a compound being unapproved is not the same as being illegal to possess Replied, post #39 · Sourcing › Regulatory · 9 Dec 2025 · 2 likes Post #36 answers the question as asked. The question underneath it is different. Where the compound being unapproved discussion usually stalls is that nobody wants to…
Tracking a preprint to publication: a worked example Replied, post #62 · Evidence › Preprints · 6 Dec 2025 · 8 likes Adding the measurement that post #61 says would settle it. Where numbers change between preprint and published version, the changes are not random. They tend toward a…
What the published dose-response for semaglutide actually looks like above 2.4 mg Started this topic · Compounds › Semaglutide · 29 Nov 2025 · 10 likes What the published dose-response for semaglutide actually looks like above 2.4 mg — that is the question, and I have not found it answered plainly anywhere I have…
Angle of injection and whether 90 degrees is always right Replied, post #55 · Practice › Administration · 24 Nov 2025 · 0 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #30 · Documentation › Doc review · 14 Nov 2025 · 0 likes Before the thread moves on from evidence digest — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of…
Documentation that materially improves an appeal's chances Replied, post #55 · Access › Insurance & coverage · 7 Nov 2025 · 26 likes Post #52 answers the question as asked. The question underneath it is different. The most useful reply I ever got about documentation was a request to state my units.…
What a purity-only report leaves out Replied, post #76 · Sourcing › Independent verification · 6 Nov 2025 · 9 likes Confirming post #74 from a second method, which matters more than confirming it from a second person. The bit of purity-only that nobody enjoys is that the answer…
EMA product information as a primary source Replied, post #37 · Regional › European Union · 6 Nov 2025 · 21 likes What I would want before treating EMA product information as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are…
Where to report an adverse event officially, by region — a second dataset Replied, post #91 · Safety › Adverse events · 4 Nov 2025 · 0 likes A report is more useful with dates, dose, timing relative to dose, and everything else being taken. Without those it cannot be assessed.
Research-use-only labelling: what it means and what it does not Replied, post #54 · Sourcing › Regulatory · 3 Nov 2025 · 8 likes Picking up post #53: that is the part I would want checked first. Trying to state the research-use-only labelling position in a way that someone who disagrees would…
A 40-week log with the measurement method stated Replied, post #88 · Outcomes › Progress reports · 28 Oct 2025 · 12 likes Nothing to add, except that this is the answer I would give if asked.
Documentation that appears only after payment Replied, post #60 · Sourcing › Red flags · 27 Oct 2025 · 7 likes Practical experience of documentation, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
Revisiting: German, French and Dutch differences, compared Replied, post #92 · Regional › European Union · 25 Oct 2025 · 10 likes I came in to disagree and I am leaving without a disagreement.
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #121 · Lounge › Off topic · 25 Oct 2025 · 0 likes Lounge question, no agenda: does anyone else keep a physical notebook for this rather than a file? Mine is more use than anything I have typed, and I cannot entirely…
Specification in the result column: why that is a meaningful error Replied, post #63 · Analytics › COA interpretation · 25 Oct 2025 · 2 likes Taking post #62 at face value and following it one step further. A document that puts the specification in the result column has told you the release criterion rather…
A 40-week log with the measurement method stated Replied, post #63 · Outcomes › Progress reports · 24 Oct 2025 · 0 likes Post #62 is right about the mechanism and I think understates the practical bit. 40-week log is one of those subjects where the general answer and the answer for a…
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #56 · Analytics › COA interpretation · 14 Oct 2025 · 23 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Persistent vomiting and the threshold for seeking help Replied, post #50 · Safety › Adverse events · 14 Oct 2025 · 0 likes I changed my mind about persistent vomiting after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
A parcel that arrived warm: a decision process, not a verdict Replied, post #78 · Practice › Storage & stability · 11 Oct 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.
Freeze-thaw and why one cycle is not the same as five Replied, post #7 · Practice › Storage & stability · 2 Oct 2025 · 0 likes Aggregation is the failure mode that most concerns anyone who works with peptides professionally and the one least visible to anyone who does not. It is also…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 1 Oct 2025 · 0 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
What I would record differently if I started again — the long version Replied, post #11 · Outcomes › Progress reports · 26 Sep 2025 · 29 likes Confirming post #9 from a second method, which matters more than confirming it from a second person. Nothing here is medical advice and a progress report is a…
Managing an unplanned gap in supply — what changed since Replied, post #62 · Access › Shortages · 14 Sep 2025 · 0 likes On post #58 — agreed on the reasoning, with one qualification. Where a manufacturer publishes a supply statement, that document is more reliable than any aggregation of…
Thyroid function tests during substantial weight change Replied, post #54 · Clinical › Bloodwork · 7 Sep 2025 · 20 likes Post #52 is right about the mechanism and I think understates the practical bit. Worth separating thyroid function tests during substantial as a question about the…
Mood changes: monitoring, and when to involve a professional — what changed since Started this topic · Wellbeing › Mental health · 4 Sep 2025 · 51 likes Mood changes: monitoring, and when to involve a professional — what changed since Writing it up because I had to work it out twice and would rather nobody else did.…
Canadian access and provincial variation — one year on Replied, post #44 · Regional › North America · 29 Jul 2025 · 10 likes Cross-border purchasing raises both a legal question and a practical one, and the legal one is yours to establish for your own jurisdiction.
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #33 · Practice › Dosing & titration · 21 Jul 2025 · 0 likes The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point at which anything is known, which is the reason to treat…
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 18 Jul 2025 · 3 likes Anyone submitting this for independent testing should say in the submission that it is an amylin analogue rather than an incretin. Method selection differs and a…
A field-by-field walk through a certificate of analysis Replied, post #15 · Analytics › COA interpretation · 14 Jul 2025 · 14 likes Coming back to post #13, because the follow-up matters more than the original answer. A chromatogram supplied as a small image is legible for peak shape and not for…
What this community means by "a source", in practical terms Replied, post #33 · Start Here › Welcome · 13 Jul 2025 · 1 like The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #24 · Compounds › Secretagogues & GH axis · 12 Jul 2025 · 4 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
Critiquing an observational claim about a class effect — one year on Started this topic · Evidence › Study critique · 29 Jun 2025 · 33 likes Critiquing an observational claim about a class effect — one year on — setting out what I have, and where I think it stops being reliable. I was wrong about Critiquing…
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #156 · Compounds › Cagrilintide & amylin analogues · 20 Jun 2025 · 0 likes Combination products complicate the certificate question considerably. Two active components mean two purity determinations and a ratio, and a single figure for a…
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #65 · Sourcing › Independent verification · 19 Jun 2025 · 22 likes I had written a reply contradicting post #62 and deleted it. Here is what survived. Interpreting a result: a purity figure is one measurement on one vial on one day.…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #66 · Nutrition & Training › Protein & intake · 11 Jun 2025 · 0 likes The practical problem is that appetite suppression makes hitting a target genuinely hard, and "eat more protein" ignores the actual constraint.
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #51 · Compounds › Retatrutide · 16 May 2025 · 0 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
DXA precision and the least significant change for lean mass — the long version Replied, post #35 · Outcomes › Body composition · 13 May 2025 · 22 likes On post #33 — agreed on the reasoning, with one qualification. I have no financial interest in anything named in this thread and I want to say so before I comment on…
Coming back to: Cross-border purchase rules within the EU Replied, post #5 · Regional › European Union · 12 May 2025 · 21 likes Movement of medicines between member states for personal use has rules, and they are published rather than a matter of custom. That is the practical version. The…
Follow-up: What other technical communities get right that we do not Replied, post #90 · Lounge › Off topic · 7 May 2025 · 1 like I will take the caveat as seriously as the claim, which is the point of putting it there.
Validating a calculator against hand arithmetic — what changed since Replied, post #45 · Data & Tools › Calculators · 2 May 2025 · 13 likes Unit-conversion tools are only as good as the assumption they make about the syringe. Ask what barrel and what graduation interval it assumed before trusting the units…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #28 · Clinical › Comorbidities · 28 Apr 2025 · 0 likes A condition that affects nutrition or absorption changes the calculus around a treatment that reduces intake, and that interaction is mostly unstudied. Not the answer,…
Follow-up: Requesting a page: what makes a good request Replied, post #24 · Documentation › Wiki requests · 21 Apr 2025 · 9 likes Format suggestions: if you think a maintained page could be clearer in its presentation (different section structure, different examples, added graphics) suggest the…
Retatrutide dose escalation in the published trials Replied, post #132 · Compounds › Retatrutide · 14 Apr 2025 · 0 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #51 · Compounds › Tirzepatide · 1 Apr 2025 · 15 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
An orphaned page with no inbound links Replied, post #21 · Meta › Wiki maintenance · 25 Mar 2025 · 5 likes That matches how I use it. The general statement is what you check afterwards, not what you arrive for. Not the whole picture, but the part of it I can speak to.
Follow-up: Requesting a page: what makes a good request Replied, post #11 · Documentation › Wiki requests · 17 Mar 2025 · 0 likes Everything in post #7 holds. The case it does not cover is the one I have. A page that would need to be rewritten every quarter is usually better as a topic with a good…
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #4 · Compounds › Retatrutide · 15 Mar 2025 · 20 likes That is a fair summary of where the discussion has got to.
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #4 · Sourcing › Independent verification · 15 Mar 2025 · 0 likes Method has to travel with the number. A verification record without the method is not a record; it is a figure. If anyone has run this properly I would rather read that…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #14 · Sourcing › Vendor reports · 15 Mar 2025 · 0 likes Where I part company with post #10, and it is a narrow parting. Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate…
Fibre intake when total intake falls, and the constipation link Replied, post #38 · Nutrition & Training › Protein & intake · 10 Mar 2025 · 0 likes Density matters more than quantity when total intake is limited. The same protein in a smaller volume is the whole game. It is worth checking rather than assuming,…
Biased agonism: a real phenomenon, an over-used explanation Replied, post #25 · Pharmacology › Receptor biology · 1 Mar 2025 · 0 likes Post #22 is right about the mechanism and I think understates the practical bit. Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #115 · Compounds › Semaglutide · 25 Feb 2025 · 15 likes This is the sort of exchange that makes the archive worth searching.
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #18 · Clinical › Comorbidities · 20 Feb 2025 · 25 likes Post-authorisation safety studies are the place where under-studied populations eventually appear, and they are public.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #24 · Compounds › Tirzepatide · 19 Feb 2025 · 0 likes The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety and energy expenditure, but how much of tirzepatide's effect is that and how…
Validating a method you did not develop — does this still hold? Replied, post #5 · marked as the solution · Analytics › Method validation · 12 Feb 2025 · 7 likes Coming back to the opening post, because the follow-up matters more than the original answer. The most useful single question about a method: what would it fail to…
How compounding permissions changed when supply normalised Replied, post #14 · Sourcing › Regulatory · 31 Jan 2025 · 6 likes Having read the whole compounding permissions thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a…
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #41 · Compounds › Semaglutide · 27 Jan 2025 · 4 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
Ipamorelin selectivity claims and where they came from Replied, post #8 · Compounds › Secretagogues & GH axis · 22 Jan 2025 · 0 likes Research-use-only secretagogues are not approved for human use. That statement is doing real work in this subcategory, where the published evidence base is thinner than…
Second pass at: Historical amylin analogues and what happened to them Replied, post #8 · Compounds › Cagrilintide & amylin analogues · 10 Jan 2025 · 13 likes Narrowing post #7, because the general version has more than one answer. For anyone arriving from searches on "amylin agonist": this subcategory discusses published…
What changed in 2026, by region Replied, post #47 · Access › International · 29 Dec 2024 · 2 likes Summaries lag badly in this area. Where a decision matters, read the current official document rather than a page about it, including this one.
Coming back to: Preparing for an appointment: one page, three questions Replied, post #133 · Clinical › Prescriber conversations · 28 Dec 2024 · 0 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. Happy to expand any of that if it is the useful part.
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #64 · Evidence › Journal club · 18 Dec 2024 · 30 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
A promotion I argued against, and why I lost Replied, post #23 · Documentation › Doc review · 7 Dec 2024 · 7 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage. The step people skip is the one I…
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #26 · Nutrition & Training › Protein & intake · 28 Nov 2024 · 11 likes I read post #22 twice before replying, because I had assumed the opposite. Micronutrient adequacy becomes a real question at very low total intake and is much less…
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #30 · Practice › Interactions · 25 Nov 2024 · 0 likes Post #28 describes the usual case. This is about the unusual one. Trying to state the Grapefruit position in a way that someone who disagrees would recognise as fair,…
Follow-up: Dead volume across syringe and needle combinations Replied, post #67 · Devices › Syringes & needles · 17 Nov 2024 · 7 likes Everything in post #63 holds. The case it does not cover is the one I have. Two claims get bundled together under Dead volume across syringe and they need separating.…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #28 · Evidence › Journal club · 9 Nov 2024 · 24 likes Post #25 is the version of this I will quote in future. One addition. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney…
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #9 · Compounds › Oral incretins · 5 Nov 2024 · 7 likes On post #5 — agreed on the reasoning, with one qualification. Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel.…
Follow-up: Dead volume across syringe and needle combinations Replied, post #56 · Devices › Syringes & needles · 28 Oct 2024 · 0 likes Dead volume across syringe was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
Converting between mg/mL and units per dose, both directions Replied, post #60 · Practice › Reconstitution · 22 Oct 2024 · 2 likes A 0.3 mL barrel has more space between graduations than a 1 mL barrel for the same volume, which is the entire practical argument for the smaller syringe. Resolution,…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #7 · Evidence › Journal club · 11 Oct 2024 · 3 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #61 · Evidence › Journal club · 2 Oct 2024 · 0 likes I keep a log for SURPASS-2 specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and settled it.
Taste changes and food aversion, reported and discussed Replied, post #19 · Practice › Side effects · 14 Sep 2024 · 5 likes Reported effects on taste and on food preference are common and interesting and unstudied in any detail. They are also the ones people find most disconcerting.
Signs of dehydration worth acting on Replied, post #9 · Safety › Adverse events · 26 Aug 2024 · 11 likes Adding a null result on signs of dehydration worth acting. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
Second pass at: Retatrutide dose escalation in the published trials Replied, post #62 · Compounds › Retatrutide · 20 Jul 2024 · 0 likes Post #59 answers the question as asked. The question underneath it is different. Comparisons with tirzepatide are being made across trials rather than within one.…
Oral contraceptives and delayed emptying: what the data shows Replied, post #33 · Practice › Interactions · 12 Jul 2024 · 0 likes Post #32 describes the usual case. This is about the unusual one. Oral contraceptives and delayed emptying is well covered in the tag pages, and the older discussions…
Cold packs, phase-change material, and what survives ten days Replied, post #57 · Sourcing › Logistics · 30 Jun 2024 · 1 like Having read the whole cold packs thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one…
Cold packs, phase-change material, and what survives ten days Replied, post #10 · Sourcing › Logistics · 12 Jun 2024 · 18 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one. Genuinely open to being wrong about this one.
The mass-error checker and its intended scope Replied, post #33 · Data & Tools › Calculators · 6 Jun 2024 · 11 likes Picking up post #32: that is the part I would want checked first. The parts-per-million mass-error calculation is simple enough to do mentally to one significant…